UTSW team find up to one-quarter of lung cancer patients ineligible for immunotherapy

(UT Southwestern Medical Center) A significant proportion of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments, a team of researchers at UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center has found.